NAF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.045600E-01
Normal-vs-Stage2
9.839600E-01
Normal-vs-Stage3
1.722590E-01
Normal-vs-Stage4
1.365840E-01
Stage1-vs-Stage2
8.002800E-01
Stage1-vs-Stage3
1.090360E-02
Stage1-vs-Stage4
1.227370E-01
Stage2-vs-Stage3
2.436400E-03
Stage2-vs-Stage4
1.263810E-03
Stage3-vs-Stage4
4.338300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.497600E-01
Normal-vs-AfricanAmerican
6.220400E-01
Normal-vs-Asian
4.628600E-01
Caucasian-vs-AfricanAmerican
4.156000E-01
Caucasian-vs-Asian
1.189250E-01
AfricanAmerican-vs-Asian
1.132410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.381400E-01
Normal-vs-Female
8.090200E-01
Male-vs-Female
2.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.217800E-01
Normal-vs-Age(41-60Yrs)
7.074000E-01
Normal-vs-Age(61-80Yrs)
9.082200E-01
Normal-vs-Age(81-100Yrs)
9.607600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.939800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.846300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.669400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.142300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.249400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.533200E-01
Normal-vs-Daily Drinker
7.215000E-01
Normal-vs-Weekly Drinker
9.581200E-01
Normal-vs-Occasional Drinker
7.704000E-01
Normal-vs-Social Drinker
7.409000E-01
Non Drinker-vs-Daily Drinker
9.957800E-01
Non Drinker-vs-Weekly Drinker
4.853400E-01
Non Drinker-vs-Occasional Drinker
1.346000E-01
Non Drinker-vs-Social Drinker
1.257560E-01
Daily Drinker-vs-Weekly Drinker
4.941800E-01
Daily Drinker-vs-Occasional Drinker
2.132000E-01
Daily Drinker-vs-Social Drinker
2.047800E-01
Weekly Drinker-vs-Occasional Drinker
7.096400E-01
Weekly Drinker-vs-Social Drinker
6.748600E-01
Occasional Drinker-vs-Social Drinker
9.405400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.932200E-02
Normal-vs-Grade 2
1.882460E-02
Normal-vs-Grade 3
1.913940E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.401600E-01
Grade 1-vs-Grade 3
2.089600E-01
Grade 1-vs-Grade 4
6.932200E-02
Grade 2-vs-Grade 3
4.021800E-01
Grade 2-vs-Grade 4
1.882460E-02
Grade 3-vs-Grade 4
1.913940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.836400E-01
Normal-vs-NonDiabetic
8.900600E-01
Diabetic-vs-NonDiabetic
6.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.723000E-01
Normal-vs-NoPancreatitis
9.966800E-01
Pancreatitis-vs-NoPancreatitis
4.325800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.834800E-01
Normal-vs-N1
9.174800E-01
N0-vs-N1
6.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.960000E-01
Normal-vs-TP53-NonMutant
7.841600E-01
TP53-Mutant-vs-TP53-NonMutant
9.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
